Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
University of Southern California Women's and Children's Hospital
mi
from
Los Angeles, CA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
University of Southern California Women's and Children's Hospital
mi
from
Los Angeles, CA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
California Pacific Medical Center
mi
from
San Francisco, CA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
California Pacific Medical Center
mi
from
San Francisco, CA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Unversity of California, San Francisco
mi
from
San Francisco, CA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Unversity of California, San Francisco
mi
from
San Francisco, CA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
University of Colorado at Denver and Health Sciences Center
mi
from
Denver, CO
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
University of Colorado at Denver and Health Sciences Center
mi
from
Denver, CO
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Hospital for Special Care
mi
from
New Britain, CT
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Hospital for Special Care
mi
from
New Britain, CT
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
George Washington University
mi
from
Washington,
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
George Washington University
mi
from
Washington,
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Mayo Clinic - Jacksonville, Florida
mi
from
Jacksonville, FL
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Mayo Clinic - Jacksonville, Florida
mi
from
Jacksonville, FL
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
University of Miami School of Medicine
mi
from
Miami, FL
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
University of Miami School of Medicine
mi
from
Miami, FL
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
ALS Center at Emory University
mi
from
Atlanta, GA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
ALS Center at Emory University
mi
from
Atlanta, GA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Med College of Georgia
mi
from
Augusta, GA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Med College of Georgia
mi
from
Augusta, GA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Northwestern University
mi
from
Chicago, IL
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Indiana University Adult Psychiatry Clinic
mi
from
Indianapolis, IN
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Indiana University Adult Psychiatry Clinic
mi
from
Indianapolis, IN
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
University of Kansas Medical Center
mi
from
Kansas City, KA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
University of Kansas Medical Center
mi
from
Kansas City, KA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
University of Kentucky Hospital
mi
from
Lexington, KY
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
University of Kentucky Hospital
mi
from
Lexington, KY
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Lahey Clinic
mi
from
Burlington, ME
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Lahey Clinic
mi
from
Burlington, ME
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Henry Ford Hospital
mi
from
Detroit, MI
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Henry Ford Hospital
mi
from
Detroit, MI
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Wayne State University
mi
from
Detroit, MI
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Wayne State University
mi
from
Detroit, MI
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Saint Mary's Healthcare
mi
from
Grand Rapids, MI
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Saint Mary's Healthcare
mi
from
Grand Rapids, MI
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Hennepin County Medical Center (Berman Center)
mi
from
Minneapolis, MN
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Hennepin County Medical Center (Berman Center)
mi
from
Minneapolis, MN
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Washington University
mi
from
St. Louis, MO
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
St. Louis Medical Center
mi
from
St. Louis, MO
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
St. Louis Medical Center
mi
from
St. Louis, MO
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
BryanLGH Medical Center
mi
from
Lincoln, NE
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
BryanLGH Medical Center
mi
from
Lincoln, NE
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
UMDNJ-Robert Wood Johnson Medical Center
mi
from
New Brunswick, NJ
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
UMDNJ-Robert Wood Johnson Medical Center
mi
from
New Brunswick, NJ
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Albany Medical Center Hospital
mi
from
Albany, NY
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Albany Medical Center Hospital
mi
from
Albany, NY
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Beth Israel Medical Center
mi
from
Boston, MA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Beth Israel Medical Center
mi
from
Boston, MA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Cornell Medical Center
mi
from
New York, NY
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Cornell Medical Center
mi
from
New York, NY
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
State University of New York - Erie Country Medical Center
mi
from
Buffalo, NY
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
State University of New York - Erie Country Medical Center
mi
from
Buffalo, NY
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Carolinas Medical Center-Myers Park
mi
from
Charlotte, NC
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Carolinas Medical Center-Myers Park
mi
from
Charlotte, NC
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
The Cleveland Clinic
mi
from
Cleveland, OH
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
The Cleveland Clinic
mi
from
Cleveland, OH
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Ohio State University
mi
from
Columbus, OH
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Ohio State University
mi
from
Columbus, OH
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Providence ALS Center
mi
from
Portland, OR
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Providence ALS Center
mi
from
Portland, OR
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Drexel University College of Medicine (Hahnemann Campus)
mi
from
Philadelphia, PA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Drexel University College of Medicine (Hahnemann Campus)
mi
from
Philadelphia, PA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Allegheny Hospital
mi
from
Pittsburgh, PA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Allegheny Hospital
mi
from
Pittsburgh, PA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
University of Pittsburgh
mi
from
Pittsburgh, PA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
University of Pittsburgh
mi
from
Pittsburgh, PA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Vanderbilt University Medical Center
mi
from
Ventura, CA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical Center
mi
from
Ventura, CA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Texas Neurology
mi
from
Dallas, TX
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
Texas Neurology
mi
from
Dallas, TX
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
The Methodist Hospital Research Institute
mi
from
Houston, TX
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
The Methodist Hospital Research Institute
mi
from
Houston, TX
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
University Of Utah Hospital
mi
from
Salt Lake City, UT
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
University Of Utah Hospital
mi
from
Salt Lake City, UT
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
University of Virginia
mi
from
Charlottesville, VA
Clinical Trial Ceftriaxone in Subjects With ALS
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Status: Archived
Updated: 1/1/1970
University of Virginia
mi
from
Charlottesville, VA
Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy: A Randomized, Parallel, Prospectively-Controlled Outpatient Comparison
Status: Archived
Orlando Regional Lucerne Hospital
mi
from
Orlando, FL
Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy: A Randomized, Parallel, Prospectively-Controlled Outpatient Comparison
Status: Archived
Updated: 1/1/1970
Orlando Regional Lucerne Hospital
mi
from
Orlando, FL
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Barrow Neurological Institute
mi
from
Phoenix, AZ
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Updated: 1/1/1970
Barrow Neurological Institute
mi
from
Phoenix, AZ
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Mayo Clinic Phoenix
mi
from
Phoenix, AZ
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Updated: 1/1/1970
Mayo Clinic Phoenix
mi
from
Phoenix, AZ
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
UCLA Medical Center
mi
from
Los Angeles, CA
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Updated: 1/1/1970
UCLA Medical Center
mi
from
Los Angeles, CA